MorphoSys AG buy Maxi_Scalibusa
Summary
This prediction ended on 31.05.11 with a price of €20.55. The BUY prediction by Maxi_Scalibusa for MorphoSys AG closed nearly unchanged. Maxi_Scalibusa has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
MorphoSys AG | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by Maxi_Scalibusa for this prediction
In the thread Morphosys AG diskutieren
schicke Aktie
Schön anzusehen, wie die Aktie Ihre Mehrjahreshochs um die 20 Euro immer wieder anläuft. Diesmal könnte der Ausbruch gelingen und eine starke Rallye einleiten. Wenn der Aufwärtstrend weiter anhält, könnte sich dieser auch schnell beschleunigen. Kursziel sind bei ca. 30 Euro, auf lange Sicht auch 60 Euro. Chance / Risiko stimmt.